Non-invasive Brain Stimulation and Occupational Therapy To Enhance Stroke Recovery (TDCS+OT)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine whether a non-painful, non-invasive, brain-stimulation technique called transcranial direct current stimulation (tDCS) combined with occupational therapy (OT) will improve motor function in patients with chronic stroke. The aim is to determine the effect of applying real (anodal and/or cathodal) vs sham (pretend) tDCS to the motor brain region to improve motor function in chronic stroke patients. Our research in normal subjects has shown that motor skills can be enhanced if tDCS is applied to the brain's motor region during motor learning. The effects after a single session of tDCS can last for up to 30 minutes, effects of multiple sessions (one session per day) can last for weeks. Furthermore, single sessions of tDCS applied to the motor regions in stroke patients have shown that improvements in motor functions can be seen and that effects may last for at least 30 minutes. Patients enrolled in this trial will be randomized to receive either real tDCS or sham tDCS in combination with OT once a day for up to 10 days. Assessments will be done by investigators who are blinded to the intervention. Patients are also blinded as to whether they are receiving real or sham tDCS. We hypothesize that real tDCS applied to the motor regions in combination with OT results in a subsequent improvement in motor function of the recovering hand over sham tDCS in combination with OT.
| Condition | Intervention | Phase |
|---|---|---|
|
Stroke Cerebrovascular Accident CVA Acute Stroke Acute Cerebrovascular Accident Apoplexy |
Device: Transcranial Direct Current Stimulation Device: Transcranial Direct Current Stimulation |
Phase 2 Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Facilitating Motor Recovery After Stroke Using tDCS |
- 3-Joint Range of Motion (3J-ROM) [ Time Frame: Two Baseline Assessments; Treatment days 5, 10; Follow Up ] [ Designated as safety issue: No ]
- Fugl-Meyer Assessment of Upper Extremity Motor Impairment [ Time Frame: Two Baseline Assessments; Treatment days 5, 10; Follow-Up ] [ Designated as safety issue: No ]
- Wolf-Motor-Function-Test [ Time Frame: Two Baseline Assessments; Treatment days 5, 10; Follow-up ] [ Designated as safety issue: No ]
- Functional MRI Activation Pattern [ Time Frame: Baseline; Follow-up ] [ Designated as safety issue: No ]
- Diffusion Tensor Imaging [ Time Frame: Baseline; Follow-up ] [ Designated as safety issue: No ]
- Transcranial Magnetic Stimulation (TMS) [ Time Frame: Baseline; Follow-up ] [ Designated as safety issue: No ]
- Motor Activity Log Rating Scales [ Time Frame: 2 Baseline Assessments; Treatment Days 5, 10; Follow-up ] [ Designated as safety issue: No ]
- Modified Ashworth Scale [ Time Frame: Baseline; Treatment days 5, 10 ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 80 |
| Study Start Date: | June 2006 |
| Estimated Study Completion Date: | December 2012 |
| Estimated Primary Completion Date: | December 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Real-tDCS + Occupational Therapy
Each subject will receive up to 10 days of traditional occupational therapy for at least 1 hour per day in the stroke recovery laboratory in combination with real transcranial direct current stimulation (tDCS) over the primary motor region for up to 45 min.
|
Device: Transcranial Direct Current Stimulation
A direct current runs between two electrode positions and affects the excitability of the underlying brain tissue
Other Names:
|
|
Sham Comparator: Sham-tDCS + Occupational Therapy
Each subject will receive up to 10 days of traditional occupational therapy for at least 1 hour per day in the stroke recovery laboratory in combination with sham (pretend) tDCS for up to 45 min. over the primary motor region.
|
Device: Transcranial Direct Current Stimulation
A sham current runs between two electrode positions and might affect the underlying brain tissue.
Other Names:
|
Eligibility| Ages Eligible for Study: | 21 Years to 80 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- First time clinical ischemic stroke or cerebrovascular accident
- At least 6 months out from first ischemic stroke prior to study enrollment
- Healthy control volunteer who has not suffered a stroke
Exclusion Criteria:
- More than 1 stroke (older strokes)
- Significant pre-stroke disability
- A terminal medical illness or disorder with survival of less than 1 year
- Co-existent major neurological or psychiatric diseases (e.g., epilepsy)
- Use of psychoactive drugs/medications - such as antidepressants,antipsychotic, stimulating agents
- Active participation in other stroke recovery trials testing interventions
Contacts and Locations| Contact: Gottfried Schlaug, MD, PhD | 617-632-8917 | stroke_recovery@yahoo.com |
| Contact: Andrea Norton, BM | 617 632-8926 | stroke_recovery@yahoo.com |
| United States, Massachusetts | |
| Beth Israel Deaconess Medical Center / Harvard Medical School | Recruiting |
| Boston, Massachusetts, United States, 02215 | |
| Contact: Gottfried Schlaug, MD, PhD 617-632-8917 gschlaug@bidmc.harvard.edu | |
| Contact: Andrea Norton 617 632-8926 stroke_recovery@yahoo.com | |
| Sub-Investigator: Robert Lindenberg, MD, PhD | |
| Sub-Investigator: Vijay Renga, MD | |
| Sub-Investigator: Dinesh Nair, MD, PhD | |
| Principal Investigator: | Gottfried Schlaug, MD, PhD | Beth Israel Deaconess Medical Center / Harvard Medical School |
More Information
Publications:
| Responsible Party: | Gottfried Schlaug, MD, PhD; Associate Professor of Neurology, Beth Israel Deaconess Medical Center / Harvard Medical School |
| ClinicalTrials.gov Identifier: | NCT00792428 History of Changes |
| Other Study ID Numbers: | 2005P-000346, NS45049 |
| Study First Received: | November 17, 2008 |
| Last Updated: | June 30, 2011 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Beth Israel Deaconess Medical Center:
|
Stroke Ischemia Infarction Cerebrovascular Disorder Central Nervous System Diseases Brain Infarction |
Brain Ischemia Rehabilitation Recovery Neurorehabilitation Plasticity |
Additional relevant MeSH terms:
|
Cerebral Infarction Stroke Brain Infarction Brain Ischemia Cerebrovascular Disorders |
Brain Diseases Central Nervous System Diseases Nervous System Diseases Vascular Diseases Cardiovascular Diseases |
ClinicalTrials.gov processed this record on May 22, 2013